You are here

cystic fibrosis

#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition

#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition

Endpoints

Vertex Pharmaceuticals

cystic fibrosis

Gilead Sciences

Flag link:

Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials

Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials

BioCentury

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie

Cystic Fibrosis Foundation Licenses Experimental Compound to AbbVie

BioSpace

cystic fibrosis

drug development

Flag link:

After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines

After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines

Stat

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

‘A game-changer’: How Vertex delivered on cystic fibrosis

‘A game-changer’: How Vertex delivered on cystic fibrosis

Stat

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients

New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients

Stat

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year

3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex deal for Scotland — no deal for England

Vertex deal for Scotland — no deal for England

Endpoints

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex sinks on reports of patient deaths tied to cystic fibrosis drug

Vertex sinks on reports of patient deaths tied to cystic fibrosis drug

Stat

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup

FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup

Endpoints

Vertex Pharmaceuticals

cystic fibrosis

tezacaftor/ivacaftor

Flag link:

What happened a year ago this week in biopharma? August 12-18, 2018

Vertex Pharmaceuticals

cystic fibrosis

Bristol-Myers Squibb

Flag link:

What happened a year ago this week in biopharma? August 12-18, 2018

What happened a year ago this week in biopharma? August 12-18, 2018

CP WIre

Vertex Pharmaceuticals

cystic fibrosis

Bristol-Myers Squibb

Flag link:

As negotiations with England labor on, Scotland rejects routine use of Vertex's cystic fibrosis drugs

As negotiations with England labor on, Scotland rejects routine use of Vertex's cystic fibrosis drugs

Endpoints

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?

Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex’s CF ‘firepower’ to fund more deals, broader pipeline

Vertex’s CF ‘firepower’ to fund more deals, broader pipeline

BioCentury

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex files cystic fibrosis triple therapy with FDA

Vertex files cystic fibrosis triple therapy with FDA

PM Live

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Orkambi parents start ‘buyers club’ to import generic version of CF drug

Orkambi parents start ‘buyers club’ to import generic version of CF drug

Pharmaforum

cystic fibrosis

Vertex Pharmaceuticals

Flag link:

Vertex to submit VX-445, Tezacaftor and Ivacaftor regimen for global regulatory approvals in cystic fibrosis

Vertex to submit VX-445, Tezacaftor and Ivacaftor regimen for global regulatory approvals in cystic fibrosis

Pharmaceutical Business Review

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Pharmas That Own Their Markets

Pharmas That Own Their Markets

Forbes

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3

Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3

Xconomy

Vertex Pharmaceuticals

cystic fibrosis

clinical trials

Flag link:

Pages